Schering-Plough Clarinex Has 12.3% New Rx Share As Of Feb. 25
Schering-Plough's Clarinex has garnered a 12.3% new prescription share as of the week of Feb. 25, Senior VP-Investor Relations & Corporate Communications Geraldine Foster said
Schering-Plough's Clarinex has garnered a 12.3% new prescription share as of the week of Feb. 25, Senior VP-Investor Relations & Corporate Communications Geraldine Foster said